Kissing Stents for Superior Vena Cava Syndrome Due to Small-Cell Lung Cancer

Superior vena cava syndrome (SVCS) is the result of obstruction to the venous flow through the superior vena cava (SVC). First described in 1757, superior vena cava syndrome (SVCS) is caused by malignancy in 80% to 90% of cases [1]. The lung neoplasia is a cause most prevalent in currently. Endovascular stentbased revascularization is used as a therapeutic measure in patients with SVC obstructions. Besides, stenting in the superior vena cava syndrome can improve the quality of life with good patency, mainly in patients with neoplasia [2]. The endovascular approach consists on treating venous obstructions while preserving the vena cava function using bilateral stenting and became an established treatment [3].